#VisualAbstract: Butylphthalide is an effective and safe neuroprotective agent for acute ischemic stroke– the BAST trial
Bookmark 1. Butylphthalide is effective — the BAST trial showed that butylphthalide is associated...
Read MoreJul 20, 2023
Bookmark 1. Butylphthalide is effective — the BAST trial showed that butylphthalide is associated...
Read MoreJul 16, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 16, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 16, 2023
Bookmark 1. The ARAMIS trial revealed that the rate of favourable neurologic function at 90 days...
Read MoreJul 8, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 8, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 8, 2023
Bookmark 1. All-cause and cardiovascular mortality rates were greater in the 24h systolic blood...
Read MoreJul 8, 2023
Bookmark 1. In this randomized controlled trial, the NmCV-5 vaccine elicited an immune response...
Read MoreJul 8, 2023
Bookmark 1. In this randomized controlled trial, patients who received transcatheter repair of...
Read MoreJul 8, 2023
Bookmark1. Patients assigned to immediate tonsillectomy had significantly fewer sore throat days...
Read MoreJul 2, 2023
Bookmark 1. In this randomized controlled trial, the treatment of gestational diabetes before 20...
Read MoreJul 2, 2023
Bookmark 1. For patients with IgA nephropathy (IgAN), long-term use of hydroxychloroquine...
Read MoreJul 2, 2023
Bookmark 1. In this randomized controlled trial, there was no difference in pediatric forearm...
Read MoreJul 2, 2023
Bookmark 1. In this randomized controlled trial, withholding prophylactic platelet transfusion in...
Read MoreJul 2, 2023
Bookmark 1. In this randomized controlled trial, early integration of palliative care among...
Read MoreJun 23, 2023
Bookmark 1. Median overall survival was greater in the pembrolizumab group compared to the control...
Read MoreJun 23, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJun 23, 2023
Bookmark 1. Patients assigned to cognitive functional therapy (CFT) reported improved...
Read MoreJun 20, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJun 15, 2023
Bookmark 1. Major amputation and all-cause mortality were higher in the vein bypass group...
Read More